daprodustat
After FDA snub, EMA backs FibroGen, Astellas’ roxadustat
Phil Taylor
Akebia Therapeutics, anaemia, Astellas, chronic kidney disease, daprodustat, EU, FibroGen, GlaxoSmithKline, Haematology, regulatory approval, roxadustat, vadadustat
0 Comment
FDA rejects FibroGen/AZ’s roxadustat, asking for new trial
Phil Taylor
AstraZeneca, chronic kidney disease, daprodustat, fda, FibroGen, GlaxoSmithKline, nephrology, roxadustat
0 Comment
FDA adcomm turns down FibroGen, AZ’s roxadustat for CKD anaemia
Phil Taylor
AstraZeneca, chronic kidney disease, daprodustat, fda, FibroGen, GlaxoSmithKline, nephrology, roxadustat
0 Comment
Astellas gets nod in Japan for roxadustat, ahead of GSK rival
Phil Taylor
Astellas, chronic kidney disease, daprodustat, FibroGen, GlaxoSmithKline, roxadustat
0 Comment